Targeting orthotopic gliomas with renal-clearable luminescent gold nanoparticles

Chuanqi Peng, Xiaofei Gao, Jing Xu, Bujie du, Xuhui Ning, Shaoheng Tang, Robert M. Bachoo, Mengxiao Yu, Woo Ping Ge, Jie Zheng

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

A major clinical translational challenge in nanomedicine is the potential of toxicity associated with the uptake and long-term retention of non-degradable nanoparticles (NPs) in major organs. The development of inorganic NPs that undergo renal clearance could potentially resolve this significant biosafety concern. However, it remains unclear whether inorganic NPs that can be excreted by the kidneys remain capable of targeting tumors with poor permeability. Glioblastoma multiforme, the most malignant orthotopic brain tumor, presents a unique challenge for NP delivery because of the blood-brain barrier and robust blood-tumor barrier of reactive microglia and macroglia in the tumor microenvironment. Herein, we used an orthotopic murine glioma model to investigate the passive targeting of glutathione-coated gold nanoparticles (AuNPs) of 3 nm in diameter that undergo renal clearance and 18-nm AuNPs that fail to undergo renal clearance. Remarkably, we report that 3-nm AuNPs were able to target intracranial tumor tissues with higher efficiency (2.3× relative to surrounding non-tumor normal brain tissues) and greater specificity (3.0×) than did the larger AuNPs. Pharmacokinetics studies suggested that the higher glioma targeting ability of the 3-nm AuNPs may be attributed to the longer retention time in circulation. The total accumulation of the 3-nm AuNPs in major organs was significantly less (8.4×) than that of the 18-nm AuNPs. Microscopic imaging of blood vessels and renal-clearable AuNPs showed extravasation of NPs from the leaky blood-tumor barrier into the tumor interstitium. Taken together, our results suggest that the 3-nm AuNPs, characterized by enhanced permeability and retention, are able to target brain tumors and undergo renal clearance. [Figure not available: see fulltext.]

Original languageEnglish (US)
Pages (from-to)1-11
Number of pages11
JournalNano Research
DOIs
StateAccepted/In press - Feb 21 2017

Fingerprint

Gold
Tumors
Nanoparticles
Brain
Blood
Tissue
Medical nanotechnology
Pharmacokinetics
Blood vessels
Glutathione
Toxicity
Imaging techniques

Keywords

  • brain tumor
  • enhanced permeability and retention
  • gold nanoparticles
  • passive targeting
  • renal clearance

ASJC Scopus subject areas

  • Materials Science(all)
  • Electrical and Electronic Engineering

Cite this

Peng, C., Gao, X., Xu, J., du, B., Ning, X., Tang, S., ... Zheng, J. (Accepted/In press). Targeting orthotopic gliomas with renal-clearable luminescent gold nanoparticles. Nano Research, 1-11. https://doi.org/10.1007/s12274-017-1472-z

Targeting orthotopic gliomas with renal-clearable luminescent gold nanoparticles. / Peng, Chuanqi; Gao, Xiaofei; Xu, Jing; du, Bujie; Ning, Xuhui; Tang, Shaoheng; Bachoo, Robert M.; Yu, Mengxiao; Ge, Woo Ping; Zheng, Jie.

In: Nano Research, 21.02.2017, p. 1-11.

Research output: Contribution to journalArticle

Peng, Chuanqi ; Gao, Xiaofei ; Xu, Jing ; du, Bujie ; Ning, Xuhui ; Tang, Shaoheng ; Bachoo, Robert M. ; Yu, Mengxiao ; Ge, Woo Ping ; Zheng, Jie. / Targeting orthotopic gliomas with renal-clearable luminescent gold nanoparticles. In: Nano Research. 2017 ; pp. 1-11.
@article{388a1f72a962499abf8c21538d72aa9b,
title = "Targeting orthotopic gliomas with renal-clearable luminescent gold nanoparticles",
abstract = "A major clinical translational challenge in nanomedicine is the potential of toxicity associated with the uptake and long-term retention of non-degradable nanoparticles (NPs) in major organs. The development of inorganic NPs that undergo renal clearance could potentially resolve this significant biosafety concern. However, it remains unclear whether inorganic NPs that can be excreted by the kidneys remain capable of targeting tumors with poor permeability. Glioblastoma multiforme, the most malignant orthotopic brain tumor, presents a unique challenge for NP delivery because of the blood-brain barrier and robust blood-tumor barrier of reactive microglia and macroglia in the tumor microenvironment. Herein, we used an orthotopic murine glioma model to investigate the passive targeting of glutathione-coated gold nanoparticles (AuNPs) of 3 nm in diameter that undergo renal clearance and 18-nm AuNPs that fail to undergo renal clearance. Remarkably, we report that 3-nm AuNPs were able to target intracranial tumor tissues with higher efficiency (2.3× relative to surrounding non-tumor normal brain tissues) and greater specificity (3.0×) than did the larger AuNPs. Pharmacokinetics studies suggested that the higher glioma targeting ability of the 3-nm AuNPs may be attributed to the longer retention time in circulation. The total accumulation of the 3-nm AuNPs in major organs was significantly less (8.4×) than that of the 18-nm AuNPs. Microscopic imaging of blood vessels and renal-clearable AuNPs showed extravasation of NPs from the leaky blood-tumor barrier into the tumor interstitium. Taken together, our results suggest that the 3-nm AuNPs, characterized by enhanced permeability and retention, are able to target brain tumors and undergo renal clearance. [Figure not available: see fulltext.]",
keywords = "brain tumor, enhanced permeability and retention, gold nanoparticles, passive targeting, renal clearance",
author = "Chuanqi Peng and Xiaofei Gao and Jing Xu and Bujie du and Xuhui Ning and Shaoheng Tang and Bachoo, {Robert M.} and Mengxiao Yu and Ge, {Woo Ping} and Jie Zheng",
year = "2017",
month = "2",
day = "21",
doi = "10.1007/s12274-017-1472-z",
language = "English (US)",
pages = "1--11",
journal = "Nano Research",
issn = "1998-0124",
publisher = "Press of Tsinghua University",

}

TY - JOUR

T1 - Targeting orthotopic gliomas with renal-clearable luminescent gold nanoparticles

AU - Peng, Chuanqi

AU - Gao, Xiaofei

AU - Xu, Jing

AU - du, Bujie

AU - Ning, Xuhui

AU - Tang, Shaoheng

AU - Bachoo, Robert M.

AU - Yu, Mengxiao

AU - Ge, Woo Ping

AU - Zheng, Jie

PY - 2017/2/21

Y1 - 2017/2/21

N2 - A major clinical translational challenge in nanomedicine is the potential of toxicity associated with the uptake and long-term retention of non-degradable nanoparticles (NPs) in major organs. The development of inorganic NPs that undergo renal clearance could potentially resolve this significant biosafety concern. However, it remains unclear whether inorganic NPs that can be excreted by the kidneys remain capable of targeting tumors with poor permeability. Glioblastoma multiforme, the most malignant orthotopic brain tumor, presents a unique challenge for NP delivery because of the blood-brain barrier and robust blood-tumor barrier of reactive microglia and macroglia in the tumor microenvironment. Herein, we used an orthotopic murine glioma model to investigate the passive targeting of glutathione-coated gold nanoparticles (AuNPs) of 3 nm in diameter that undergo renal clearance and 18-nm AuNPs that fail to undergo renal clearance. Remarkably, we report that 3-nm AuNPs were able to target intracranial tumor tissues with higher efficiency (2.3× relative to surrounding non-tumor normal brain tissues) and greater specificity (3.0×) than did the larger AuNPs. Pharmacokinetics studies suggested that the higher glioma targeting ability of the 3-nm AuNPs may be attributed to the longer retention time in circulation. The total accumulation of the 3-nm AuNPs in major organs was significantly less (8.4×) than that of the 18-nm AuNPs. Microscopic imaging of blood vessels and renal-clearable AuNPs showed extravasation of NPs from the leaky blood-tumor barrier into the tumor interstitium. Taken together, our results suggest that the 3-nm AuNPs, characterized by enhanced permeability and retention, are able to target brain tumors and undergo renal clearance. [Figure not available: see fulltext.]

AB - A major clinical translational challenge in nanomedicine is the potential of toxicity associated with the uptake and long-term retention of non-degradable nanoparticles (NPs) in major organs. The development of inorganic NPs that undergo renal clearance could potentially resolve this significant biosafety concern. However, it remains unclear whether inorganic NPs that can be excreted by the kidneys remain capable of targeting tumors with poor permeability. Glioblastoma multiforme, the most malignant orthotopic brain tumor, presents a unique challenge for NP delivery because of the blood-brain barrier and robust blood-tumor barrier of reactive microglia and macroglia in the tumor microenvironment. Herein, we used an orthotopic murine glioma model to investigate the passive targeting of glutathione-coated gold nanoparticles (AuNPs) of 3 nm in diameter that undergo renal clearance and 18-nm AuNPs that fail to undergo renal clearance. Remarkably, we report that 3-nm AuNPs were able to target intracranial tumor tissues with higher efficiency (2.3× relative to surrounding non-tumor normal brain tissues) and greater specificity (3.0×) than did the larger AuNPs. Pharmacokinetics studies suggested that the higher glioma targeting ability of the 3-nm AuNPs may be attributed to the longer retention time in circulation. The total accumulation of the 3-nm AuNPs in major organs was significantly less (8.4×) than that of the 18-nm AuNPs. Microscopic imaging of blood vessels and renal-clearable AuNPs showed extravasation of NPs from the leaky blood-tumor barrier into the tumor interstitium. Taken together, our results suggest that the 3-nm AuNPs, characterized by enhanced permeability and retention, are able to target brain tumors and undergo renal clearance. [Figure not available: see fulltext.]

KW - brain tumor

KW - enhanced permeability and retention

KW - gold nanoparticles

KW - passive targeting

KW - renal clearance

UR - http://www.scopus.com/inward/record.url?scp=85013426230&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85013426230&partnerID=8YFLogxK

U2 - 10.1007/s12274-017-1472-z

DO - 10.1007/s12274-017-1472-z

M3 - Article

SP - 1

EP - 11

JO - Nano Research

JF - Nano Research

SN - 1998-0124

ER -